High total PDCD4 expression levels correlated with improved 5-year survival in primary melanomas, Figure 2a (log-rank test, p = 0.038; Risk Ratio (RR) 0.704; Lower Confidence Limit (CL) 0.491; Upper CL 0.97, p = 0.031). The gene discussed is PDCD4; the disease is melanoma.